文献速递免疫规划卫生政策与健康促进

欧洲疫苗接种联合行动:提升疫苗接种覆盖率的研究优先领域

Research priorities to increase vaccination coverage in Europe (EU joint action on vaccination).
PubMed 文献 · Vaccine · 2021-09-28

该研究采用多准则决策分析(MCDA)方法,在欧盟疫苗接种联合行动框架下建立研究优先领域设定框架。针对百日咳、含麻疹成分联合疫苗、流感及HPV四种试点疫苗,通过广泛咨询产生124个问题,经筛选后对27个问题进行排序,最终由国际专家达成六项最高优先研究问题共识。

要点

  • 采用MCDA方法建立透明、循证的疫苗研究优先领域设定框架。
  • 四种试点疫苗咨询产生124个问题,筛选后27个问题进入排序。
  • 国际专家最终达成六项最高优先研究问题共识。

核心结论

  • 建立了透明、循证的严谨框架以确定关键研究问题,为提升疫苗覆盖率的政策与策略设计生成证据。
  • 研究结果已广泛传播并提交欧盟委员会,拟在Horizon Europe计划下申请资助。
  • 同一流程将于2021年用于确定欧盟所有疫苗及COVID-19疫苗的接种研究优先领域。

研究设计与样本

  • 采用受Rudan等儿童健康与营养研究倡议启发的多准则决策分析(MCDA)定量方法。
  • 流程包括广泛咨询识别关键研究问题、专家组选择优先准则、另一专家组通过两两比较确定准则权重、最终专家组对每个研究问题按加权准则评分并排序。
  • 工作聚焦于四种预选试点疫苗:百日咳、含麻疹成分联合疫苗、流感及HPV疫苗。

主要发现

  • 广泛咨询共产生124个问题,经整理和改写后得到27个待排序问题。
  • 设定的优先准则包括:可及性、可回答性、可实施性、疾病患病率/发病率、有效性、公平性、可推广性及地域性。
  • 在最终面对面会议上,国际专家对27个问题进行排序,并达成六项最高优先问题的共识列表。

关键数值与推荐

  • 优先准则共八项:可及性、可回答性、可实施性、疾病患病率/发病率、有效性、公平性、可推广性及地域性。
  • 共识产出为六项最高优先研究问题。

临床怎么用

  • 可为疫苗研究资助方和决策者提供透明、循证的研究优先领域设定工具。
  • 识别的六项最高优先研究问题可指导提升疫苗覆盖率的研究投入方向。
  • 框架可扩展至欧盟所有疫苗及COVID-19疫苗的研究优先领域设定。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Deciding how best to invest in healthcare is never an easy task and prioritization is therefore an area of great interest for policymakers. Too low public vaccine confidence, which results in insufficient vaccine uptake, remains an area of concern for EU policy-makers. Within the European Joint action on vaccination, a work-package dedicated to research aims to define tools and methods for priority-setting in the field of vaccination research. We therefore propose a prioritization framework to identify research priorities towards generating and synthesizing evidence to support policies and strategies aiming at increasing vaccine coverage. MATERIALS/METHODS: We used a multi-criteria decision analysis (MCDA) method inspired by the Child Health and Nutrition Research Initiative developed by Rudan et al. This quantitative methodology follows a series of steps involving different groups of experts and relevant stakeholders. The first step consists in identifying key research questions through a broad consultation. In parallel, a first group of experts is tasked to select criteria for prioritization of research questions, taking into consideration the ultimate goal of the exercise. Another group of experts is then requested to assess a weight to each of the criteria, using pair-wise comparisons. The final step consists in gathering experts who will assess each research question against the weighted criteria. This evaluation leads to assigning a score to each individual research question, which can then be ranked in order of priority. RESULTS: We focused our work on four pre-selected pilot vaccines (pertussis, measles containing combination vaccines, influenza and HPV). The consultation generated 124 questions, which were secondarily sorted and re-worded to obtain 27 questions to be ranked. Criteria for setting priorities were the following: accessibility, answerability, deliverability, disease prevalence/incidence, effectiveness, equity, generalization, and territory. During a final face-to-face meeting international experts ranked the 27 questions and agreed on a consensual list of six top-priorities. CONCLUSIONS: We have developed a transparent, evidence-based rigorous framework to defined key research questions to generate evidence towards the design of policies and strategies to increase vaccine coverage. Results were disseminated broadly and submitted to the EC for potential funding in the context of The Horizon Europe Program. The same process will be conducted in 2021 to identify vaccination research priorities regarding all vaccines used in the EU as well as COVID-19 vaccines.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Francis-Oliviero F, Bozoki S, Micsik A, et al. Research priorities to increase vaccination coverage in Europe (EU joint action on vaccination). Vaccine. 2021. PMID: 34598823. doi:10.1016/j.vaccine.2021.09.033

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。